- AU$62.47m
- AU$50.74m
- AU$114.62m
CEO
Australia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million
Brief: Somnomed Ltd Posts Q4 FY25 Revenue Of A$30.1M
Brief: Somnomed Posts Q3 FY25 Revenue Of A$27.7 Million
Australia's SomnoMed falls on potential US tariff-induced risks
Brief: Somnomed Says H1 Revenue AUD 53.7 Million
Brief: Somnomed Posts Q2 Fy25 Revenue Of A$28.5 Mln, Up 19.8%
Australia's SomnoMed surges to near 1-1/2-year high on forecast upgrade
Brief: Somnomed Says Q1 FY25 Revenue At A$25.3 Million, Up 18.2%
Australia's Somnomed eyes best day in nearly 17 yrs on FY forecast upgrade
Brief: Somnomed Posts Q1 Fy25 Revenue Of A$25.3 Million
Brief: Somnomed Ltd Says US FDA Cleared Rest Assure As Oral Device
Brief: Somnomed Sees FY25 EBITDA Of More Than A$5 Million
Brief: Somnomed Posts FY Loss From Ordinary Activities After Tax Attributable A$12.2 Million
Brief: Somnomed Says FY24 EBITDA Guidance Revised To Between A$0.3 Mln & A$0.8 Mln